The field of genomics is paving the way for more effective medical treatments than ever before. Based on a patient’s individual genetic make-up and flagged sequences or mutations, genomics research can not only tell us the diseases that a person is most at risk from now or in the future but also how they will respond to particular treatments.
For conditions with strong links to lifestyle (e.g. diabetes, cancer and heart disease), pharma companies recognise that their major treatments may only be effective in 30 to 60 per cent of the population. But with Genomics to guide clinical decision making on individual treatment plans (translational medicine), patient outcomes for these diseases and many others could improve considerably.
To deliver personalised medicine in our lifetime, genomic researchers are studying our genetic material to see how it is affected by certain diseases and looking at how gene therapy can alter our genetic makeup to give us a healthier future.
However, one person’s genome generates 200GB of information so there is great demand for data scientists, analysts and bioinformaticians who can take a vast amount of data and make it useful for the development of gene therapy and drug targets. The comparison of multiple genomes also requires epidemiologists to look for patterns and variances using statistical methods.
Paramount has an exclusive partnership with Genomics England to place the brightest minds in the industry on its ground-breaking 100,000 Genomes Project, the world’s largest national sequencing project of its kind. Mapping the genomes of around 70,000 people, participants on the project include NHS patients with a rare disease plus their families, and patients with cancer.
Genomics jobs can be found at educational and research institutions like Genomics England, as well as in pharma companies, so for candidates looking for opportunities in the market they are many and varied. If you are interested in finding out more about jobs in genomics, check out our latest vacancies here.